The role of lipid peroxidation in the pathogenesis of experimental diabetic retinopathy

The aim of work - to analysis of changes in the level of primary products of lipid peroxidation in experimental animals were simulated diabetic retinopathy and against the background of its correction. The obtained results indicate an increase in the content of lipid peroxidation, starting from the...

Full description

Saved in:
Bibliographic Details
Main Authors: Y. Sirman (Author), I. Savytskyi (Author)
Format: Book
Published: Kazimierz Wielki University, 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d6ffc99a6de44bbbb47e7122de61fd0a
042 |a dc 
100 1 0 |a Y. Sirman  |e author 
700 1 0 |a I. Savytskyi  |e author 
245 0 0 |a The role of lipid peroxidation in the pathogenesis of experimental diabetic retinopathy 
260 |b Kazimierz Wielki University,   |c 2021-02-01T00:00:00Z. 
500 |a 10.12775/JEHS.2021.11.2.032 
500 |a 2391-8306 
520 |a The aim of work - to analysis of changes in the level of primary products of lipid peroxidation in experimental animals were simulated diabetic retinopathy and against the background of its correction. The obtained results indicate an increase in the content of lipid peroxidation, starting from the 30th and with further progression on the 60th and 180th days of experimental diabetic retinopathy, which is confirmed by an increase in the level of diene conjugates in the 2nd group, the maximum of which is observed at the 3rd stage. Correction with hypoglycemic agents in the 3rd group had a positive effect, but was not able to reduce the level of primary products of lipid peroxidation and restore antioxidant activity, so the use of additional agents became necessary. The use of aflibercept and a nitric oxide donor in the 4th group to correct the development of diabetic retinopathy significantly suppressed oxidative stress, the maximum of which occurred on the 180th day of the experiment, but did not reach control indicators. It was proven that the combined administration of bromfenac and aflibercept in the 5th group significantly reduced the number of primary LPO products, but not as significantly as in the 4th group. It was proved that the administration of aflibercept, L-carnitine and bromfenac to the animals of the 6th group reduced the content of diene conjugates already on the 30th and continued on the 60th and 180th days of the study, but it also did not reach the control indicators. The combination of metformin, aflibercept, L-arginine and citicoline in rats of the 7th group proved to be the most effective correction, as evidenced by the normalization of the level of the studied indicators on the 30th and 60th days of the experiment, and on the 180th, a decrease in the content of markers was detected oxidative stress to control indicators. 
546 |a EN 
546 |a ES 
546 |a PL 
546 |a RU 
546 |a UK 
690 |a experimental diabetic retinopathy 
690 |a streptozotocin diabetes 
690 |a inflammation 
690 |a lipid peroxidation 
690 |a diene conjugates 
690 |a correction 
690 |a Education 
690 |a L 
690 |a Sports 
690 |a GV557-1198.995 
690 |a Medicine 
690 |a R 
655 7 |a article  |2 local 
786 0 |n Journal of Education, Health and Sport, Vol 11, Iss 2 (2021) 
787 0 |n https://apcz.umk.pl/JEHS/article/view/40285 
787 0 |n https://doaj.org/toc/2391-8306 
856 4 1 |u https://doaj.org/article/d6ffc99a6de44bbbb47e7122de61fd0a  |z Connect to this object online.